Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
- Conditions
- Liver TransplantationLiver Transplant Recipients
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2016-09-02
- Target Recruit Count
- 202
- Registration Number
- NCT01672164
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Mayo Clinic, Phoenix, Arizona, United States
Clinical Outcomes of People Who Acquired HIV in Early Life
- Conditions
- HIV
- First Posted Date
- 2012-08-03
- Last Posted Date
- 2023-03-09
- Target Recruit Count
- 177
- Registration Number
- NCT01656564
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
- Conditions
- Pneumococcal Infection
- Interventions
- Biological: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2017-03-27
- Target Recruit Count
- 884
- Registration Number
- NCT01654263
- Locations
- 🇺🇸
Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
🇺🇸Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States
🇺🇸Group Health Research Institute - Seattle - Vaccines and Infectious Diseases, Seattle, Washington, United States
Influenza Antiviral DAS-181-F04 in Healthy Adults
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2017-04-07
- Target Recruit Count
- 9
- Registration Number
- NCT01651494
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center - Infectious Diseases, Baltimore, Maryland, United States
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 54
- Registration Number
- NCT01649869
- Locations
- 🇺🇸
Children's of Alabama Child Health Research Unit (CHRU), Birmingham, Alabama, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
🇺🇸Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease, Washington, District of Columbia, United States
Influenza A 2009 H1N1 Challenge Study in Healthy Adults
- Conditions
- Influenza
- Interventions
- Biological: Ca/04/2009/H1N1 Vero Grown Challenge Virus
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2016-05-09
- Target Recruit Count
- 49
- Registration Number
- NCT01646138
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule
- Conditions
- Bacillus Anthracis (Anthrax)
- Interventions
- Biological: BioThrax®
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2014-05-28
- Target Recruit Count
- 328
- Registration Number
- NCT01641991
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
🇺🇸Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States
🇺🇸Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
- Conditions
- ImmunosuppressionLiver Transplant RecipientsLiver Transplantation
- Interventions
- Drug: Immunosuppression withdrawal
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2019-10-07
- Target Recruit Count
- 161
- Registration Number
- NCT01638559
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇨🇦The Hospital for Sick Children, Toronto, Ontario, Canada
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
- Conditions
- HIV Infections
- Interventions
- Drug: FTC 200 mg/TDF 300 mg fixed-dose combination tablet
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2021-11-05
- Target Recruit Count
- 557
- Registration Number
- NCT01632995
- Locations
- 🇺🇸
SF City Clinic Non-Network CRS, San Francisco, California, United States
🇺🇸Whitman Walker Non-network CRS, Washington, District of Columbia, United States
🇺🇸Miami PrEP Non-Network CRS, Miami, Florida, United States
Gene Expression in HIV and Tuberculosis Co-infection
- Conditions
- Tuberculosis
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2018-04-05
- Target Recruit Count
- 96
- Registration Number
- NCT01611402
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States